Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-8-19
pubmed:abstractText
The nonnucleoside reverse transcriptase inhibitor (NNRTI) efavirenz undergoes phase I metabolism by the cytochrome P450 enzyme, CYP2B6. Previous studies outside of the United Kingdom have shown associations between the CYP2B6 polymorphism G516T and increased toxicity. This study aimed to develop a CYP2B6 G516T genotyping assay to identify individuals at risk of efavirenz toxicity. The frequency of this polymorphism in a UK HIV-infected population and its prevalence in individuals who had discontinued efavirenz were also to be assessed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1468-1293
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
520-3
pubmed:meshHeading
pubmed-meshheading:19486190-Adult, pubmed-meshheading:19486190-African Continental Ancestry Group, pubmed-meshheading:19486190-Aged, pubmed-meshheading:19486190-Aged, 80 and over, pubmed-meshheading:19486190-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:19486190-Benzoxazines, pubmed-meshheading:19486190-Cohort Studies, pubmed-meshheading:19486190-European Continental Ancestry Group, pubmed-meshheading:19486190-Female, pubmed-meshheading:19486190-Gene Frequency, pubmed-meshheading:19486190-Genotype, pubmed-meshheading:19486190-Great Britain, pubmed-meshheading:19486190-HIV Infections, pubmed-meshheading:19486190-Humans, pubmed-meshheading:19486190-Male, pubmed-meshheading:19486190-Medication Adherence, pubmed-meshheading:19486190-Middle Aged, pubmed-meshheading:19486190-Oxidoreductases, N-Demethylating, pubmed-meshheading:19486190-Polymerase Chain Reaction, pubmed-meshheading:19486190-Polymorphism, Single Nucleotide, pubmed-meshheading:19486190-Reverse Transcriptase Inhibitors, pubmed-meshheading:19486190-Young Adult
pubmed:year
2009
pubmed:articleTitle
CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation.
pubmed:affiliation
Department of Biochemistry, University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, Bristol, UK. Victoria.Powers@UHBristol.nhs.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't